More recently, a retrospective analysis of 105 patients with GC demonstrated that increased CCL5 serum levels correlated with more advanced T and N stages, poorly- or undifferentiated histological types, peritoneal metastasis, higher rates of residual tumor, and shorter survival [100]. Here, CCL5 is linked to neoplasm.